Diagnosis of hepatitis C virus infection in Scotland's injecting drug user population

Epidemiology and Infection

Volumn 138, Issue 3, 2010, Pages 393-402

  Mcdonald, S A ^a   Hutchinson, S J ^a,b   Mills, P R ^c   Bird, S M ^b,d   Robertson, C ^a,b   Dillon, J F ^e   Springbett, A ^f   Goldberg, D J ^a  

^a HEALTH PROTECTION SCOTLAND   (United Kingdom)

^b UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^c GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e UNIVERSITY OF DUNDEE   (United Kingdom)

^f INFORMATION SERVICES DIVISION   (United Kingdom)

Author keywords

Epidemiology; Hepatitis C; Injecting drug users (IDUs)

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DELAYED DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; DRUG MISUSE; FEMALE; HEALTH STATUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; POPULATION RISK; RISK FACTOR; SELF INJECTION; SEX DIFFERENCE; SOCIAL ISOLATION; UNITED KINGDOM; AGE DISTRIBUTION; COHORT ANALYSIS; ISOLATION AND PURIFICATION; MIDDLE AGED; RETROSPECTIVE STUDY; RISK; SUBSTANCE ABUSE;

ADULT; AGE DISTRIBUTION; COHORT STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; SCOTLAND; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

EID: 76549112570     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268809990616     Document Type: Article

References (27)

1. Amon J, et al. Prevalence of hepatitis C virus infection among injection drug users in the United States ; 1994-2004. Clinical Infectious Diseases 2008; 46: 1852-1858.
2. Hagan H, Des Jarlais D. HIV and HCV infection among injecting drug users. Mount Sinai Journal of Medicine 2000; 67: 423-428.
3. Roy K, et al. Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature. Epidemiology and Infection 2002; 129: 577-585.
4. Hutchinson S, et al. Modelling the spread of hepatitis C virus infection among injecting drug users in Glasgow: Implications for prevention. International Journal of Drug Policy 2006; 17: 211-221.
5. Hutchinson S, et al. Hepatitis C virus infection in Scotland: epidemiological review and public health challenges. Scottish Medical Journal 2006; 51: 8-15.
6. Roy K, et al. Hepatitis C virus infection among injecting drug users in Scotland: a review of prevalence and incidence data and the methods used to generate them. Epidemiology and Infection 2007; 135: 433-442.
7. National Institute for Health and Clinical Excellence (NICE). Peginterferon alfa and ribavirin for the treatment of mild chronic hepatitis C. London: NICE, 2006.
8. Scottish Intercollegiate Guidelines Network (SIGN). Management of hepatitis C. A national clinical guideline. Edinburgh: Scottish Intercollegiate Guidelines Network (SIGN). December, 47 pp. (SIGN publication, no. 92), 2006.
9. Scottish Government Health Department. Hepatitis C action plan for Scotland: Phase II : May 2008-March 2011. Edinburgh: Scottish Government, 2008.
10. Health Protection Scotland and the University of the West of Scotland. The Needle Exchange Surveillance Initiative (NESI): Prevalence of HCV, HIV and injecting risk behaviours among injecting drug users attending needle exchanges in Scotland, 2007. Glasgow: Health Protection Scotland, May, 2008.
11. Cook P, et al. Predictors of hepatitis B and C infection in injecting drug users both in and out of drug treatment. Addiction 2001; 96: 1787-1797.
12. Stein M, Maksad J, Clarke J. Hepatitis C disease among injection drug users : knowledge; perceived risk and willingness to receive treatment. Drug and Alcohol Dependence 2001; 61: 211-215.
13. Shaw L, et al. Establishment of a database of diagnosed HCV-infected persons in Scotland. Communicable Disease and Public Health 2003; 6: 305-310.
14. Health Protection Scotland (HPS). Surveillance of known hepatitis C antibody positive cases in Scotland: results to 30 June 2006. HPS Weekly Report: Health Protection Scotland, 2006, pp. 202-206.
15. Bird S, Hutchinson S, Goldberg DJ. Drug-related deaths by region; sex ; and age group per 100 injecting drug users in Scotland, 2000-2001. Lancet 2003; 362: 941-944.
16. Hay G, et al. Estimating the national and local prevalence of problem drug misuse in Scotland: Executive report. Edinburgh: ISD, 2005.
17. Kendrick S, Clarke J. The Scottish Record Linkage System. Health Bulletin (Edinburgh) 1993; 51: 72-79.
18. Carstairs V, Morris R. Deprivation and health in Scotland. Health Bulletin 1990; 48: 162-175.
19. McLoone P. Carstairs scores for Scottish postcode sectors from the 2001 Census. Glasgow: MRC Social & Public Health Sciences Unit, 2004.
20. Efron B. Bootstrap methods: another look at the jacknife. Annals of Statistics 1979; 7: 1-26.
21. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2006.
22. Taylor A, et al. Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working? Journal of Infection 2000; 40: 176-183.
23. Hutchinson S, et al. Hepatitis C virus among childbearing women in Scotland: prevalence ; deprivation; and diagnosis. Gut 2004; 53: 593-598.
24. Taylor A, et al. Evaluation of the Lord Advocate's guidance on the distribution of sterile needles and syringes to injecting drug users. Edinburgh: Scottish Executive (Effective Interventions Unit). 2005.
25. Health Protection Agency HPS, National Public Health Service for Wales, CDSC Northern Ireland, CRDHB. Shooting up: infections among injecting drug users in the UK 2006. An update: October 2007. London: Health Protection Agency, 2007.
26. National Centre in HIV Epidemiology and Clinical Research. Australian NSP Survey National Data Report 2002-2006. Sydney, NSW: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, 2007.
27. Meffre C, et al. Surveillance of screening for hepatitis C through the laboratory network RENA-VHC, France, 2000-2001. Eurosurveillance 2003; 8: 101-107.